Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Patrick Soon-Shiong / Hagens Berman

Patrick Soon-Shiong & Hagens Berman

3 shared events · Importance 3 · Last updated May 27, 2026

Importance
3
Shared Events
3
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (3)
82
Regulatory
ImmunityBio Faces Securities Fraud Lawsuits
Patrick Soon-Shiong: Patrick Soon-Shiong, ImmunityBio's Executive Chairman and Chief Scientific and Medical Officer, is accused of materially overstating Anktiva's capabilities, leading to the FDA warning and subsequent lawsuits.
Hagens Berman: Hagens Berman is investigating claims that ImmunityBio violated federal securities laws and is urging investors with significant losses to join their class action lawsuit.
Apr 02, 2026 · 132 articles
0
Regulatory
ImmunityBio Faces Securities Class Actions
Apr 01, 2026 · 45 articles
0
Business
ImmunityBio Faces Anktiva Misrepresentation Lawsuits
Apr 01, 2026 · 64 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Patrick Soon-Shiong and Hagens Berman interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.